Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Recro Pharma Names CCO

This article was originally published in Scrip

Executive Summary

Recro Pharma Inc., a specialty pharma company developing non-opioid therapies for pain, has appointed Fred Graff chief commercial officer. Graff brings more than 20 years' experience to Recro and started his career at Rhone Poulenc Rorer where he held various roles including director of sales, US cardiovascular division. Previously he was senior vice president of sales at Sepracor Pharmaceuticals and later he was vice president of sales at Vanda Pharmaceuticals.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC064555

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel